SEC Insider Transactions from DUNCAN BARBARA GAYLE.

Last updated: 2026-05-08 13:12 UTC | Total transactions: 21

DUNCAN BARBARA GAYLE has filed 21 insider transactions across 3 companies since February 2023.

Most recent transaction: a grant/award of 6040 shares of HALOZYME THERAPEUTICS, INC. ($HALO) on May 05, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
May 5, 2026 HALOZYME THERAPEUTICS, INC. $HALO DUNCAN BARBARA GAYLE Director A Option to Purchase Common Stock 6040 $0.00 6,040.0000 123,904,000 9999.99% 0.00%
May 5, 2026 HALOZYME THERAPEUTICS, INC. $HALO DUNCAN BARBARA GAYLE Director A Common Stock 3796 $0.00 23,715.0000 123,904,000 19.06% 0.00%
Feb. 26, 2026 Ovid Therapeutics Inc. $OVID DUNCAN BARBARA GAYLE Not found A Employee Stock Option (Right to Buy) 65000 $0.00 65,000.0000 71,212,353 9999.99% 0.09%
June 20, 2025 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found M Restricted Stock Units 29600 $0.00 0.0000 85,525,179 100.00% 0.03%
June 20, 2025 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found M Common Stock 29600 $0.00 62,750.0000 85,525,179 89.29% 0.03%
June 20, 2025 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found A Restricted Stock Units 29600 $0.00 29,600.0000 85,525,179 9999.99% 0.03%
June 20, 2025 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found A Stock Option (Right to Buy) 41200 $0.00 41,200.0000 85,525,179 9999.99% 0.05%
Feb. 20, 2025 Ovid Therapeutics Inc. $OVID Duncan Barbara Gayle Not found A Stock Option (right to buy) 45000 $0.00 45,000.0000 0 9999.99% 0.00%
May 1, 2025 HALOZYME THERAPEUTICS, INC. $HALO Duncan Barbara Gayle Not found A Common Stock 4165 $0.00 19,919.0000 129,424,000 26.44% 0.00%
May 1, 2025 HALOZYME THERAPEUTICS, INC. $HALO Duncan Barbara Gayle Not found A Option to Purchase Common Stock 5750 $0.00 5,750.0000 129,424,000 9999.99% 0.00%
Dec. 12, 2024 Ovid Therapeutics Inc. $OVID Duncan Barbara Gayle Not found A Stock Option (Right to Buy) 90000 $0.00 90,000.0000 0 9999.99% 0.00%
June 21, 2024 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found A Stock Option (Right to Buy) 41200 $0.00 41,200.0000 0 9999.99% 0.00%
June 21, 2024 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found A Restricted Stock Units 29600 $0.00 29,600.0000 0 9999.99% 0.00%
June 16, 2024 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found M Restricted Stock Units 33150 $0.00 0.0000 0 100.00% 0.00%
June 16, 2024 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Not found M Common Stock 33150 $0.00 33,150.0000 0 9999.99% 0.00%
April 25, 2024 HALOZYME THERAPEUTICS, INC. $HALO Duncan Barbara Gayle Not found A Common Stock 6501 $0.00 15,754.0000 134,197,000 70.26% 0.00%
April 25, 2024 HALOZYME THERAPEUTICS, INC. $HALO Duncan Barbara Gayle Not found A Option to Purchase Common Stock 8804 $0.00 8,804.0000 134,197,000 9999.99% 0.01%
Feb. 22, 2024 Ovid Therapeutics Inc. $OVID Duncan Barbara Gayle Director A Stock Option (Right to Buy) 30000 $0.00 30,000.0000 0 9999.99% 0.00%
June 16, 2023 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Director A Restricted Stock Units 33150 $0.00 33,150.0000 0 9999.99% 0.00%
June 16, 2023 Atea Pharmaceuticals, Inc. $AVIR Duncan Barbara Gayle Director A Stock Option (Right to Buy) 46750 $0.00 46,750.0000 0 9999.99% 0.00%
Feb. 23, 2023 Ovid Therapeutics Inc. $OVID Duncan Barbara Gayle Director A Stock Option (Right to Buy) 15000 $0.00 15,000.0000 0 9999.99% 0.00%